Preliminary report of profile FSH and LH of the COVID-19 survivors in Surabaya, Indonesia

Eni Maria Sisca,Andri Rezano,Cennikon Pakpahan,Supardi Supardi,Agustinus Agustinus,Ninik Darsini,Maitra Djiang Wen,Tiara Kirana,Ria Margiana
DOI: https://doi.org/10.53730/ijhs.v6ns3.6054
2022-04-15
International Journal of Health Sciences
Abstract:Endocrine dysfunction in COVID-19 plays a role in clinical issues related to different disorders, including, hypogonadism, anxiety, stress and depression. Hypogonadism as an essential determinant for COVID-19-related pathogenesis which regulates the link between the brain and testes. In Indonesia, there is no studying about FSH and LH in COVID-19 survivors. Research design was cross sectional. We conducted this study at the Department of Biomedical Science Faculty of Medicine,, Universitas Airlangga Surabaya, Indonesia. A total of 34 male participants that recovery from COVID-19 enrolled, only 18 participants meet the criteria included. We conducted anamnesis, physical examination including height, weight, waist circumference and we analyzed hormone by using immunoflouroscene analyzer VIDAS and the ELFA method. Normal levels of FSH and LH were 1-8 IU / L and LH 2–10 IU / L, respectively. The mean age of COVID-19 survivors was 36.56 ± 5.69 while the mean marriage duration was 9.56 ± 6.17. The majority of participants had comorbid obesity class I of 6/18 (28.57%) with a mean waist circumference was 91.00 ± 11.68. Mild type COVID-19 was the most frequent 9/18 (50.0%). There were 3/18 (16.7%) pneumonia confirmed COVID-19, but only 2/3 pneumonia confirmed COVID-19 that had elevated FSH and LH levels.
What problem does this paper attempt to address?